Articles

Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trials

Schludi B, Giugliano RP, Sabatine MS, et al.

Journal: 

J Clin Lipidol

First published: June 6, 2022  DOI: 10.1016/j.jacl.2022.05.069

Abstract


Full Article